Comparable Renal Function at 6 Months with Tacrolimus Combined with Fixed-Dose Sirolimus or MMF: Results of a Randomized Multicenter Trial in Renal Transplantation

<table>Estimated rate of patients free from biopsy-confirmed acute rejection (Kaplan-Meier method). The estimated rate of patients free from BCAR (Kaplan-Meier method) at 6 months was 83.8% in the Tac/SRL group and 87.1% in the Tac/MMF group (difference between groups <math id="M50" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo>-</mo></mrow></math>3.0%; 95% confidence interval: <math id="M51" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo>-</mo></mrow></math>8.9% to 2.4% [Greenwood formula]).</table>

Journal of Transplantation

fig3

Figure 3

Figure 3: Comparable Renal Function at 6 Months with Tacrolimus Combined with Fixed-Dose Sirolimus or MMF: Results of a Randomized Multicenter Trial in Renal Transplantation 

Figure 3 | Comparable Renal Function at 6 Months with Tacrolimus Combined with Fixed-Dose Sirolimus or MMF: Results of a Randomized Multicenter Trial in Renal Transplantation 